ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 301477 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 301477; 2) Community: the network communities that were significantly associated with the response to NSC 301477; 3) Molecule: the relationships between components within communities and NSC 301477; 4) MDR: the compounds that were significantly associated with the NSC 301477.

NSC Compound Enrichment Correlation
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.0352383000003058 0.22521964
NSC 672058 Null 0.0352383000003058 0.051046275
NSC 672974 Null 0.0352383000003058 0.61620749
NSC 673787 Null 0.0352383000003058 0.25744127
NSC 676466 Null 0.0352383000003058 0.36261752
NSC 677041 Null 0.0352383000003058 0.17733222
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0352383000003058 0.1248116
NSC 681632 Camptothecin Derivative 0.0352383000003058 0.69588124
NSC 684144 Null 0.0352383000003058 0.14724795
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.0352383000003058 0.39933135
Total:132  Current:96    [First] [Prev] [Next] [Last]